JPS5549311A - Preparation of stable solid medicine for internal use containing 1-carbamoyl-5-fluorouracils as active constituent - Google Patents
Preparation of stable solid medicine for internal use containing 1-carbamoyl-5-fluorouracils as active constituentInfo
- Publication number
- JPS5549311A JPS5549311A JP12160378A JP12160378A JPS5549311A JP S5549311 A JPS5549311 A JP S5549311A JP 12160378 A JP12160378 A JP 12160378A JP 12160378 A JP12160378 A JP 12160378A JP S5549311 A JPS5549311 A JP S5549311A
- Authority
- JP
- Japan
- Prior art keywords
- carbamoyl
- fluorouracils
- stable solid
- solid medicine
- internal use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
PURPOSE: To obtain a stable solid medicine for internal use, by compounding oncostatic 1-carbamoyl-5-fluorouracils and specific additives for medicinal use.
CONSTITUTION: 1-Carbamoyl-5-fluorouracil or its derivative cabbreviated as CFU) is compounded with specific additives for medicinal use, characterized by (1) having low chemical activity, (2) having mederate hydrophilic property and reducing the hydrophobic property of the principal constituent, (3) containing no hydroxyl group having high reactivity with isocyanates, and (4) giving a neutral or acidic saturated aqueous solution or suspension. The additive is, for example, a diluent such as CMC, starchs, lactose, etc.; a binding agent such as PVA, methylcellulose, etc.; a disintegrating agent such as starchs, CMC, etc.; a lubricant such as potassium stearate, etc. CFU which is unstable in the presence of conventional additives is stabilized to obtain the title medicine which keeps its medicinal effect without lowering the disintegration and dissolution properties.
COPYRIGHT: (C)1980,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12160378A JPS5549311A (en) | 1978-10-04 | 1978-10-04 | Preparation of stable solid medicine for internal use containing 1-carbamoyl-5-fluorouracils as active constituent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12160378A JPS5549311A (en) | 1978-10-04 | 1978-10-04 | Preparation of stable solid medicine for internal use containing 1-carbamoyl-5-fluorouracils as active constituent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5549311A true JPS5549311A (en) | 1980-04-09 |
Family
ID=14815332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12160378A Pending JPS5549311A (en) | 1978-10-04 | 1978-10-04 | Preparation of stable solid medicine for internal use containing 1-carbamoyl-5-fluorouracils as active constituent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5549311A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5528006A (en) * | 1978-08-18 | 1980-02-28 | Konishiroku Photo Ind Co Ltd | Information recording device |
-
1978
- 1978-10-04 JP JP12160378A patent/JPS5549311A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5528006A (en) * | 1978-08-18 | 1980-02-28 | Konishiroku Photo Ind Co Ltd | Information recording device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8404804D0 (en) | PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE AND WITH A HIGH CONTENT OF ACTIVE INGREDIENT | |
EP0244178A3 (en) | Intraocular dosage compositions and method of use | |
ZA902139B (en) | A moderated spun fibrous system and method of manufacture | |
ES2064112T3 (en) | PHARMACEUTICAL COMPOSITION FOR QUICK SUSPENSION IN WATER. | |
KR890015745A (en) | Pharmaceutical composition of pyricampum present in aqueous solution and preparation method thereof | |
ES8506621A1 (en) | Benzenesulphonyl lactams, process for their preparation and their use as active ingredients in pharmaceutical compounds | |
JPS53109555A (en) | Preparation of modified keratin-containing material | |
HU901617D0 (en) | Herbicide compositions containing {[(1,3,5-triazin-2-yl)-amino-carbonyl]-amino-sulfonyl}-benzoic acid esters and process for the preparation of the active ingredients | |
JPS5549311A (en) | Preparation of stable solid medicine for internal use containing 1-carbamoyl-5-fluorouracils as active constituent | |
EP0159777A1 (en) | Stabilized 4-carbamoyl-imidazolium-5-olate | |
IE870410L (en) | Amphoteric surfactant for contact lenses | |
JPS57159839A (en) | Stabilized aqueous acrylamide polymer solution | |
JPS57140723A (en) | Preventing composition for hyperlipemia due to neutral fat | |
JPS57200361A (en) | "indomethacin(r)" pharmaceutical with low irritant action | |
ES2047540T3 (en) | PHARMACEUTICAL COMPOUND AND PROCEDURE FOR ITS PREPARATION. | |
TW374692B (en) | Stable mixtures of incompatible active ingredients for plant protection | |
JPS55149209A (en) | Composition for rectal administration | |
US4579960A (en) | Stable solutions containing thimerosal | |
JPS5742620A (en) | Novel antiulcer agent | |
JPS54105222A (en) | Solid lysozyme preparation | |
JPS5675428A (en) | Hypoglycemic agent containing procainamide hydrochloride | |
JPS565412A (en) | Pharmaceutical composition | |
JPS5612309A (en) | Oral drug containing ubidecarenone | |
BG49313A1 (en) | Method for preparing mixed ethers of many- atomic alcohols | |
JPS643123A (en) | Remedy for skin inflammation |